The observed beneficial response of M30 on cognitive functions may be associated with the inhibitory effect of the drug on Aβ levels and tau phosphorylation since a clear relationship has been demonstrated between Aβ accumulation and tau hyperphosphorylation and the cognitive deficits of AD Tg mouse model [166,167,168]. This evidence concerns the gene MAPT and Alzheimer disease.